Epigenetics in Alzheimer's Disease: a Focus on DNA Modifications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|31|3398-3412

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.31, 2011-10, pp. : 3398-3412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imaging Epigenetics in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-11 ,pp. : 6393-6415

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

By Bonda David J.   Mailankot Maneesh   Stone Jeremy G.   Garrett Matthew R.   Staniszewska Magdalena   Castellani Rudy J.   Siedlak Sandra L.   Zhu Xiongwei   Lee Hyoung-gon   Perry George   Nagaraj Ram H.   Smith Mark A.  

Redox Report, Vol. 15, Iss. 4, 2010-08 ,pp. : 161-168

Maney Publishing

Access to resources Recommend Favorite

Treatment Strategies in Alzheimer’s Disease with a Focus on Early Pharmacological Interventions

By Marksteiner J.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 415-426

Adis International

Access to resources Recommend Favorite

Abeta DNA Vaccination for Alzheimer's Disease: Focus on Disease Prevention

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-01 ,pp. : 207-216

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetics and dermatological disease

By Millington George WM  

Pharmacogenomics, Vol. 9, Iss. 12, 2008-12 ,pp. : 1835-1850

Future Medicine

Access to resources Recommend Favorite